Mycophencolate mofetil (an IMPDH1 inhibitor) could inhibit HCC cell proliferation in vitro, suggesting that the genes in the predictive model are a potential therapeutic target in HCC. The gene discussed is IMPDH1; the disease is hepatocellular carcinoma.